01 1Dasami Lab
01 1NIMODIPINE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-02-15
Pay. Date : 2018-10-26
DMF Number : 32971
Submission : 2018-10-01
Status : Active
Type : II
20
Dasami Lab Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is NIMODIPINE, with a corresponding US DMF Number 32971.
Remarkably, this DMF maintains an Active status since its submission on October 01, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 15, 2019, and payment made on October 26, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
